Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.

Journal of Autoimmunity
M KrilisB Giannakopoulos

Abstract

Β2-Glycoprotein I (β2GPI) is an important anti-thrombotic protein and is the major auto-antigen in the antiphospholipid syndrome (APS). The clinical relevance of nitrosative stress in post translational modification of β2GPI was examined.The effects of nitrated (n)β2GPI on its anti-thrombotic properties and its plasma levels in primary and secondary APS were determined with appropriate clinical control groups. β2-glycoprotein I was nitrated at tyrosines 218, 275 and 309. β2-glycoprotein I binds to lipid peroxidation modified products through Domains IV and V. Nitrated β2GPI loses this binding (p < 0.05) and had diminished activity in inhibiting platelet adhesion to vWF under high shear flow (p < 0.01). Levels of nβ2GPI were increased in patients with primary APS compared to patients with either secondary APS (p < 0.05), autoimmune disease without APS (p < 0.05) or non-autoimmune patients with arterial thrombosis (p < 0.01) and healthy individuals (p < 0.05).In conclusion tyrosine nitration of plasma β2GPI is demonstrated and has important implications with regards to the pathophysiology of platelet mediated thrombosis in APS. Elevated plasma levels of nβ2GPI in primary APS may be a risk factor for thrombosis warranting further ...Continue Reading

References

Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H P McNeilS A Krilis
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
May 15, 2002·Annals of the Rheumatic Diseases·C VitaliUNKNOWN European Study Group on Classification Criteria for Sjögren's Syndrome
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·Z M Ruggeri
Dec 19, 2003·The Journal of Biological Chemistry·Caryn VadsethHarry Ischiropoulos
Jul 25, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jim C Oates, Gary S Gilkeson
Jan 24, 2007·Physiological Reviews·Pál PacherLucas Liaudet
Jan 1, 2008·Expert Review of Clinical Immunology·Paul R J AmesAnnamaria Margarita
Jan 25, 2011·Molecular BioSystems·Zexian LiuYu Xue
Mar 15, 2013·The New England Journal of Medicine·Bill Giannakopoulos, Steven A Krilis
Jan 10, 2018·Journal of Thrombosis and Haemostasis : JTH·G ObermayerC J Binder
May 29, 2018·Proceedings of the National Academy of Sciences of the United States of America·Rafael Radi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.